8th NovAliX Conference

Biophysics in Drug Discovery 2021 | US Edition

Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs

 Boston, MA, United States    March 10-12, 2021

Programme


09:00

Registration

10:45

Welcome Address

Session 1: Hot Topics

Session Chair

11:00

Oral Communication 01

11:15

Oral Communication 02

11:30

Oral Communication 03

11:45

Oral Communication 04

12:00

Oral Communication 05

12:15

Oral Communication 06

12:30

Lunch, Exhibition & Networking

Session 2 : Induced-Proximity Drug Discovery : Selective Protein Degraders, PPI Stabilizers, etc.

14:00

Session Chair

14:00

Title to be confirmed (IL01)

Dr Dirksen BUSSIERE
NOVARTIS, Emeryville, United States

14:30

Speaker to be confirmed

15:00

Speaker to be confirmed

15:30

Coffee Break

18:30

Welcome Reception

19:30

End of the day

09:00

Welcome Coffee & Registration

Cryo-EM in Drug Discovery - Accelerating Drug Design of Challenging Targets a full day session organized by Thermo Fisher Scientific, Platinum Sponsor of the NovAliX Conference

Session chair

09:40

Title to be confirmed (IL07)

Prof. Patrick M. SEXTON
MONASH UNIVERSITY, Parkville, Australia

10:20

Title to be confirmed (IL08)

Dr Christopher ARTHUR
GENENTECH, San Francisco, United States

11:00

Coffee Break

11:30

Title to be confirmed (IL09)

Dr Kasim SADER
THERMO FISHER SCIENTIFIC, Cambridge, United Kingdom

12:10

Informercial NovAliX

12:20

Title to be confirmed (IL10)

Dr Jamie HANNAH
THERMO FISHER SCIENTIFIC, Boston, United States

12:35

Lunch, Exhibition & Networking

14:00

Title to be confirmed (IL11)

Dr Corey STRICKLAND
MERCK & CO. INC (MSD), Whitehouse station, United States

14:40

Speaker to be confirmed

15:20

Informercial NIS

15:30

Coffee Break

Panel Discussion

16:00

Dr Christopher ARTHUR
GENENTECH, San Francisco, United States
Dr Jamie HANNAH
THERMO FISHER SCIENTIFIC, Boston, United States
Dr Kasim SADER
THERMO FISHER SCIENTIFIC, Cambridge, United Kingdom
Prof. Patrick M. SEXTON
MONASH UNIVERSITY, Parkville, Australia
Dr Corey STRICKLAND
MERCK & CO. INC (MSD), Whitehouse station, United States

17:00

End of the day

19:30

Conference Dinner

08:30

Registration

Session 4 : Covalent Modifications for Drug Discovery

Session Chair

09:00

Title to be confirmed (IL13)

Prof. Daniel NOMURA
UC BERKELEY, Berkeley, United States

09:30

Speaker to be confirmed

10:00

Speaker to be confirmed

10:30

Coffee Break

11:00

Keynote Speaker

Prof. Michelle ARKIN
UNIVERSITY OF CALIFORNIA, San Francisco, United States

12:00

Lunch, Exhibition & Networking

Session 5 : Integrative Structural Biology & Biophysics

14:00

Session Chair

14:00

Title to be confirmed (IL16)

Prof. Patrick GRIFFIN
THE SCRIPPS RESEARCH INSTITUTE, Jupiter, United States

14:30

Title to be confirmed (IL17)

Dr Daniel WYSS
MERCK, Kenilworth, United States

15:00

Speaker to be confirmed

15:30

Poster Prizes and Closing Remarks

15:45

End of the Conference